Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,268 | 20,208 | 6,166 | 4,081 | 5,083 |
| Other current assets | 0 | 0 | 0 | 0 | 345 |
| TOTAL | $18,838 | $21,933 | $7,193 | $4,222 | $5,638 |
| Non-Current Assets | |||||
| PPE Net | 92 | 116 | 22 | 88 | 141 |
| Other Non-Current Assets | 823 | 0 | 0 | 0 | 0 |
| TOTAL | $915 | $116 | $22 | $88 | $141 |
| Total Assets | $19,753 | $22,050 | $7,215 | $4,309 | $5,778 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,541 | 1,043 | 818 | 1,277 | 831 |
| TOTAL | $1,850 | $1,168 | $899 | $1,343 | $1,047 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 671 | 0 | 0 | 0 | 0 |
| TOTAL | $671 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,521 | $1,168 | $899 | $1,343 | $1,047 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26 | 26 | 3 | 3 | 2 |
| Common Shares | 46 | 29 | 5 | 5 | 40 |
| Retained earnings | -127,353 | -111,374 | -101,401 | -94,669 | -87,656 |
| Other shareholders' equity | 0 | 0 | 0 | -31 | 0 |
| TOTAL | $17,232 | $20,882 | $6,316 | $2,966 | $4,731 |
| Total Liabilities And Equity | $19,753 | $22,050 | $7,215 | $4,309 | $5,778 |